Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.
about
Gene Expression Control by Glucocorticoid Receptors during Innate Immune ResponsesGlucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malariaCANDO and the infinite drug discovery frontierCross-fostering increases TH1/TH2 expression in a prenatal dexamethasone exposure rat model.Corticosteroid therapy for hearing and balance disordersEffects of Cellular 11β-hydroxysteroid Dehydrogenase 1 on LPS-induced Inflammatory Responses in Synovial Cell Line, SW982.Cortisol biosynthesis in the human ocular surface innate immune response.Loss of c-REL but not NF-κB2 prevents autoimmune disease driven by FasL mutation.A CYP21A2 based whole-cell system in Escherichia coli for the biotechnological production of premedrol.Microarray-based gene expression profiling reveals the mediators and pathways involved in the anti-arthritic activity of Celastrus-derived Celastrol.Progesterone and autoimmune disease.Nuclear receptors in inflammation control: repression by GR and beyond.Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment.Pro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids.Treatment of chronic inflammatory demyelinating polyneuropathy: from molecular bases to practical considerations.Context-dependent cooperation between nuclear factor κB (NF-κB) and the glucocorticoid receptor at a TNFAIP3 intronic enhancer: a mechanism to maintain negative feedback control of inflammation.The HPA - Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain.Cortisol and depression: three questions for psychiatry.The neuroendocrine control of the innate immune system in health and brain diseases.Adipose tissue inflammation and cancer cachexia: the role of steroid hormones.Skin Metabolite, Farnesyl Pyrophosphate, Regulates Epidermal Response to Inflammation, Oxidative Stress, and Migration.Relating drug-protein interaction network with drug side effects.Human autoimmune diseases: a comprehensive update.Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies.The Role of Immune Checkpoint Inhibition in the Treatment of Brain Tumors.Control of proinflammatory gene programs by regulated trimethylation and demethylation of histone H4K20.The effect of systemic corticosteroids on the innate and adaptive immune system in children with steroid responsive nephrotic syndrome.Resiniferatoxin modulates the Th1 immune response and protects the host during intestinal nematode infection.Resiniferatoxin lowers TNF-α, NO and PGE2 in the intestinal phase and the parasite burden in the muscular phase of Trichinella spiralis infection.Impact of loss of NF-κB1, NF-κB2 or c-REL on SLE-like autoimmune disease and lymphadenopathy in Fas(lpr/lpr) mutant mice.Virus-drug interactions--molecular insight into immunosuppression and HCV.Decreased lymphocytes and increased risk for infection are common in endogenous pediatric Cushing syndrome.Therapeutic Effects of Resiniferatoxin Related with Immunological Responses for Intestinal Inflammation in Trichinellosis.Drug-resistant Th17 cells: culprits in steroid-refractory Crohn's disease?Regulatory effects of dexamethasone on NK and T cell immunity.The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer.
P2860
Q26752615-DA235A8F-1775-49D0-B654-7BE8EC7AB1C5Q28535601-FFFE5FCB-C793-4406-9135-53502C9FB725Q28543019-BBBE3505-6C04-49DC-98E7-C5B8263D0D1CQ30422417-B6310DA3-0D8B-4C41-B804-4299F2B0775CQ30439597-CE458833-FC93-41F8-BF5F-5B3878B0A07CQ33835112-22E9AE1C-CC21-4C6E-BBFA-0ACB6932BED6Q35149219-773FA076-859D-4FA0-B6C7-AB37BE0E416BQ35349474-52C02996-27BF-44D1-AB1F-37BD37ACDEE9Q36067176-7F2BF273-1D68-4C62-AD68-8975880BB54AQ36074393-DACD0317-EE9E-43B2-8CFF-042E9C0806F8Q36202227-9BBFB1C8-400E-44DB-95D4-5D5F29D23864Q37209671-F52916E4-EF8C-4766-B383-F17034D6FCC4Q37403811-45786A22-7D56-44B5-A824-442BD5677679Q37483138-2C5CC201-D691-419A-9FEA-5886AB954F6DQ37557375-384A8DB8-A8F6-47AA-B2F2-BCCA854E6FBEQ37653249-D239ED2A-760C-4E55-B63F-A26C1929F2EBQ37689538-18BD0DA8-AE64-47E5-8BCA-08B7D1BC8CD8Q38008032-13A2C656-F030-4359-8BD9-352BAA20757BQ38020956-7A5D0EAC-AAFF-422E-AF28-49B4CB074863Q38265265-FDC8F678-8248-4A5B-9927-9C782DCCD619Q38293571-CA08597A-20A2-4BD6-AA95-280B9A1DAE35Q38495130-7200EEEB-DA57-4E33-921E-C0F9BB6DFF3CQ38554722-8B00DCDC-5387-4718-9848-FCF3995C33DDQ38750548-BCDFC685-A013-49E4-9626-2390C4AC262BQ38930244-69A308D8-4EA4-4AD0-9975-6D8DA6DD80CFQ39291348-5EDCAAC2-FCB9-4076-87FC-FF7B7F15DF94Q40035174-31136138-439B-40DE-BC75-4CE6EF395334Q40173020-380EE406-E961-4A48-BD1D-630A7515EF49Q40506129-7D541634-BEED-418C-A4DA-38EB807FDC69Q41154690-B8FAC2B9-1B4D-4FCB-BCE5-005F7770D6F9Q45358300-A200F2CB-856D-495C-87B5-59D0851CA046Q47359004-7C08F1B6-E10E-408D-AB0F-1EF110EFC011Q47555989-6BBB5B90-AF81-496C-9A31-193A2E580EA7Q48074137-FAB22124-9FD2-4274-9F3A-D7BAF3843B7EQ48265824-0A2C1798-1392-4E6F-8A55-F0CE8F93E89DQ48291586-80BB5F48-959F-4D8E-B49D-73CA7102CB75
P2860
Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.
@ast
Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.
@en
type
label
Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.
@ast
Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.
@en
prefLabel
Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.
@ast
Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.
@en
P2860
P356
P1476
Minireview: Glucocorticoids in autoimmunity: unexpected targets and mechanisms.
@en
P2093
Inez Rogatsky
Jamie R Flammer
P2860
P304
P356
10.1210/ME.2011-0068
P577
2011-04-21T00:00:00Z